- About Us -

Drug Discovery



NAEJA-RGM Pharmaceuticals Inc. is a global, early drug discovery organization specializing in “Hit” and “Lead” Validation, Lead Optimization and Drug Candidate Selection research. The company was formed from the assets of NAEJA Pharmaceutical Inc. including key staff critical to the most successful NAEJA Pharmaceutical programs.

The NAEJA-RGM scientists have played a major role in the discovery and early development of literally hundreds of leads and drug candidates. The main focus of the NAEJA-RGM business is proprietary drug discovery work. Initiatives are under way to create a contract-research division.

“Antimicrobial resistance is currently responsible for over 700,000 deaths annually around the world. AMR mortality is predicted to exponentially rise to above 10 million deaths per year by 2050. The global economic cost of such a rise in mortality and morbidity is estimated to be $100 trillion.”   

-Industry Canada


Our Research is Part of a Global Initiative

NAEJA-RGM will focus on its primary area of expertise: medicinal chemistry applied to infectious disease research. Growth in antimicrobial resistance has led to global initiatives to tackle this problem. We are perfectly positioned to take advantage of our experience in this area.

NAEJA-RGM’s pipeline of antibiotic and beta-lactamase inhibitor projects is designed to attack dangerous bacterial infections that have garnered global attention.

Research Pipeline


Pre-Clinical Development

Beta-Lactam-Antibiotics Drug-Discovery


We are currently accepting proposals for contract research in Pre-Clinical Discovery and Custom Services - medicinal chemistry programs.

Contact Us

Our guiding philosophy is a tribute to our inspirational mentor, the late Dr. Ronald G. Micetich: To strive for excellence, think outside the box, and collaborate seamlessly with partners by applying over 30 years of institutional expertise in early drug discovery and development.


“It is the lone worker who makes the first advance in a subject: the details may be worked out by a team, but the prime idea is due to the enterprise, thought, and perception of an individual.”

-Alexander Fleming